Correlation between the changes in the objective parameters and the symptom scores in the patients with FD treated with LG21
| Stomach-related parameters | Symptoms | |||
|---|---|---|---|---|
| Δ (epigastric pain-like)* | Δ (postprandial distress-like)* | |||
| r | p Value | r | p Value | |
| GF | ||||
| Δ (volume) | 0.11† | 0.49 | 0.07† | 0.65 |
| Δ (pH) | 0.06‡ | 0.69 | 0.04‡ | 0.82 |
| Δ (no. of cultured bacteria) | 0.01‡ | 0.93 | 0.05‡ | 0.76 |
| Δ (abundance of Prevotella) | 0.38‡ | 0.07 | 0.52‡ | 0.009 |
| Δ (serum PGI) | 0.07‡ | 0.67 | 0.07‡ | 0.64 |
*Δ score (before LG21 treatment−after LG21 treatment).
†Pearson's product–moment correlation coefficient.
‡Spearman's rank correlation coefficient.
FD, functional dyspepsia; GF, gastric fluid; LG21, Lactobacillus gasseri OLL2716.